Dr. Abram Medhat Soliman, MD

Dr. Soliman practices at Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center.

Dr. Soliman's NPI, 1962082545, was assigned on April 8, 2021. Dr. Soliman graduated from University of Assiut Faculty of Medicine in 2016. Dr. Soliman holds California license A194798.

Dr. Soliman's primary practice is Eisenhower Health, at 39-000 Bob Hope Drive, Rancho Mirage, CA 92270 in Riverside County. The practice phone is (760) 340-3911. Dr. Soliman also practices at Eisenhower Medical Center, 39000 Bob Hope Dr, Rancho Mirage, CA 92270.

Dr. Soliman's primary practice is Eisenhower Health in Rancho Mirage, California, part of Eisenhower Medical Center. The medical group on file is Eisenhower Health. Dmand AI also links Dr. Soliman to 1 more breast imaging center, 1 clinical lab, 1 dialysis center and 1 home health agency, each named with a free account. Dr. Soliman's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Soliman practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Soliman's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Soliman is licensed in California.

CMS data shows 244 Medicare services from Dr. Soliman across 5 procedure codes in 2024, for 215 Medicare patients. Medicare paid $17,528 for them.

CMS counts 215 Medicare patients who saw Dr. Soliman in 2024. The largest group is 65 to 74, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Soliman's median patient age at 74, with 47% women.

In 2024, Dr. Soliman wrote 446 Medicare Part D claims for 132 patients. 86% of them were for generic drugs. CMS names the drug for 176 of them, across 11 drugs with 11 or more claims each, at $15,089 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Dr. Soliman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Soliman, published from 2023 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents, Drug Eruptions and Lung Neoplasms. Dr. Soliman has published most often in J Oncol Pharm Pract. Dr. Soliman's most frequent co-authors are Constantin Dasanu, MD, PhD and Steven C. Plaxe, MD.

CMS Open Payments shows 21 general payments to Dr. Soliman from 12 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $397.

Dr. Soliman graduated from University of Assiut Faculty of Medicine in 2016.

Dr. Soliman is in network with 11 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.